Heyholder
‹ Activism Filings

EASY BIO, Inc. Q3 operating profit KRW 11.5 billion, up 2.6% from a year earlier

EASY BIO, Inc.· Periodic Report

AI summary · Not investment advice

EasyBio sold KRW 140.0 billion worth in Q3 and made KRW 11.5 billion from its main business, up 2.6% from a year earlier and down 23.4% from the prior quarter.

Operating profit · 3 months

KRW 11.5 billion

Key facts

Revenue (3 months)
KRW 140.0 billion
Net income (3 months)
KRW 1.2 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 116.9 billion
Revenue (year to date)
KRW 418.9 billion
Operating profit (prior-year 3 months)
KRW 11.2 billion
Operating profit (year to date)
KRW 39.8 billion
Net income (prior-year 3 months)
KRW 8.6 billion
Net income (year to date)
KRW 23.8 billion

Commentary

AI commentary · Not investment advice

What happened

EG Bio reported its consolidated results for the 3rd quarter of 2026 in its quarterly report. Sales for the latest 3 months were KRW 140.03 billion. In the same 3 months a year earlier, sales were KRW 116.90 billion. Cumulative sales this year are KRW 418.86 billion.

In the company's terms

Sales rose 19.8% from a year earlier. They fell 5.5% from the previous quarter.

What changes for shareholders

Operating profit (profit from the core business) for the latest 3 months was KRW 11.53 billion. That is 2.6% above the KRW 11.25 billion of a year earlier. It is 23.4% below the previous quarter. Cumulative operating profit this year is KRW 39.81 billion.

Net income (the final profit after taxes and other costs) for the latest 3 months was KRW 1.24 billion. That is 85.7% below the KRW 8.63 billion of a year earlier. It is 88.6% below the previous quarter. Cumulative net income this year is KRW 23.76 billion.

Comments

No comments yet

Comments from shareholders will appear here.